Axa’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-29,700
Closed -$411K 1121
2023
Q3
$411K Buy
+29,700
New +$434K ﹤0.01% 962
2020
Q2
Sell
-30,600
Closed -$72K 1285
2020
Q1
$72K Sell
30,600
-563,400
-95% -$3.65M ﹤0.01% 1149
2019
Q4
$6.24M Buy
+594,000
New +$5.38M 0.03% 567
2016
Q4
Sell
-79,232
Closed -$1.77M 1282
2016
Q3
$1.77M Sell
79,232
-105,868
-57% -$2.13M 0.01% 787
2016
Q2
$3.95M Buy
185,100
+85,800
+86% +$1.62M 0.02% 608
2016
Q1
$1.75M Sell
99,300
-13,900
-12% -$207K 0.01% 776
2015
Q4
$1.71M Buy
+113,200
New +$1.74M 0.01% 808

Other funds holding PTEN

Axa's PTEN Position: Q4 2023 in Review

Axa sold out of Patterson-UTI (PTEN) in Q4 2023, closing a stake of 29,700 shares — an estimated $411K sold.

Axa first reported a position in PTEN in Q4 2015 and held it in 7 quarters. The position peaked at $6.24M in Q4 2019. 359 funds tracked by Wall St. Rank hold PTEN as of Q4 2023.

  • Axa reported no remaining Patterson-UTI position as of Q4 2023 after selling out during the quarter.
  • Axa sold 29,700 Patterson-UTI shares in Q4 2023, an estimated $411K.
  • Axa first reported a position in Patterson-UTI in Q4 2015 and held it in 7 quarters.
  • Axa's Patterson-UTI position peaked at $6.24M in Q4 2019.
  • 359 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2023.

Based on Axa's 13F filing for Q4 2023, filed 14 Feb 2024.